'Before the pandemic, RSV was the No. 1 cause of infant hospitalization in the United States, so this is a big deal.'
An FDA advisory panel is considering whether to recommend approval of a respiratory syncytial virus vaccine for infants."Before the pandemic, RSV was the No. 1 cause of infant hospitalization in the United States, so this is a big deal," Ofer Levy, MD, the director of the Precision Vaccines Program at Boston Children's Hospital, told Levy is a temporary voting member of the FDA advisory panel but is not involved in this vote, which the FDA is not required to follow.
The vaccine, which is made by Pfizer, would be given to pregnant women in their final trimester, with the protection being passed through the placenta to the unborn baby.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA Advisory Panel Recommends RSV Vaccine for Pregnant WomenAn FDA advisory panel has recommended that the FDA approve an RSV vaccine for pregnant women. The vaccine would be given in the final trimester, with protection from RSV being passed through the placenta to the unborn baby.
Leer más »
FDA panel recommends the first shot to prevent RSV in infants by vaccinating pregnant mothersBREAKING: FDA panel recommends first shot to prevent RSV in infants by vaccinating pregnant mothers. If the shot gets approved, it would be the first RSV vaccine that confers protection to babies.
Leer más »
First RSV vaccine to protect infants wins backing of FDA panelThe first vaccine to protect babies from the respiratory virus RSV is a step closer to approval, after a panel of the Food and Drug Administration's outside vaccine advisers voted to back the safety and effectiveness of a new shot developed by Pfizer.
Leer más »
FDA Panel Backs RSV Vaccine for Moms to Protect BabyA panel of experts voted to approve Pfizer’s new RSV vaccine designed to protect infants from the virus during their most vulnerable first six months of life. Learn more here.
Leer más »
FDA advisers vote in favor of Pfizer maternal RSV vaccineAdvisers to the U.S. Food and Drug Administration voted Thursday in favor of Pfizer’s respiratory syncytial virus vaccine for pregnant people. FDA advisory...
Leer más »